Blog

Antibodies are versatile molecules that perform a range of effector functions, many of which engage different arms of the immune system. Their modes of action extend beyond simple antigen binding, enabling the activation of various immune mechanisms that lead to pathogen neutralization and clearance. These functions include blocking molecular interactions, activating the complement system, and linking the humoral immune response to cellular immune responses via Fc receptor engagement.

In today’s competitive biotech landscape, intellectual property (IP) protection has become an essential pillar in fostering innovation and collaboration across drug discovery and development. By offering clear IP terms and no royalty fees,pharmaceutical companies and research institutes

In addition to isotypes and subtypes, antibodies exhibit genetic variation known as allotypes, which are polymorphic epitopes on immunoglobulins. These allotypic differences arise from allelic variations in immunoglobulin genes, causing certain antibody subtypes to differ between individuals or ethnic groups. The presence of these polymorphic forms can influence immune responses, particularly when an individual is exposed to a non-self allotype, potentially triggering an anti-allotype immune reaction.

In mammals, antibodies are classified into five major isotypes: IgA, IgD, IgE, IgG, and IgM. Each isotype is defined by the heavy chain it contains: alpha (IgA), delta (IgD), epsilon (IgE), gamma (IgG), or mu (IgM). These structural differences in the heavy chains determine the antibody's function, tissue localization, and role in the immune response. Furthermore, antibody light chains fall into two classes—kappa and lambda—with kappa being more common, though both exhibit similar functions despite differences in sequence.

Antibody generation can be approached through two main methods: in vivo (within a living organism) and in vitro (in a laboratory setting). Below is a comparison of their advantages, drawbacks, and technical differences.AdvantagesCategoryIn VivoIn VitroAntigen Format CompatibilityBroad, including nat

Antibodies, a key element of the immune system, play dual roles through two distinct structural regions: the antigen-binding fragment (Fab) and the crystallizable fragment (Fc). These regions not only bind antigens but also trigger immune responses that facilitate antigen clearance. The Fab region,

Monoclonal antibodies (mAbs) are essential tools in therapeutic development, diagnostics, and research. Among the various methods for generating human monoclonal antibodies, two popular technologies are: phage display and transgenic mice. While both methods have their merits, transgenic mice are particularly valuable for creating fully human antibodies through the natural immune processes of the animal.

The history of antibodies traces back several centuries and forms the cornerstone of modern immunology. From the early discovery of immunity through exposure to disease, to the detailed molecular understanding of antibodies today, the development of antibody research has been transformative for both basic science and applied biotechnology, particularly in therapeutic antibody production.

Phage display leverages the natural biology of bacteriophages to study protein interactions. Bacteriophages consist of a protein coat that encapsulates either a DNA or RNA genome. Their structural simplicity or complexity varies, but they all share a fundamental ability to inject their genetic material into host cells, making them ideal tools for molecular biology applications.

The terms in vivo and in vitro represent distinct approaches in scientific research, each contributing to advancements in medical knowledge while possessing unique limitations. In vivo refers to studies conducted within a living organism, while in vitro describes research performed in a controlled laboratory environment, such as in a test tube or petri dish.

Welcome to Biointron's Antibody Basics! In this episode we’ll talk about next-generation antibody formats, specifically multispecific (& tetraspecific) antibodies.

The use of microfluidics to precisely control fluid behavior in micro- and nano-environments has enabled the development of advanced platforms like lab-on-a-chip and organ-on-a-chip systems. These technologies have drastically improved our ability to conduct high-through